Impact of HER2-low status on axillary response and surgical management after neoadjuvant chemotherapy in early breast cancer

被引：0
|
作者：
da Silva, Leonardo Roberto
Sartori, Guilherme
Ramalho, Susana
Reinert, Tomas
Da Rosa, Mahira Lopes
Tavares, Grazielle Morais
Mantovani, Higor
Vasconcelos, Vivian
Cabello, Ana Elisa Ribeiro Da Silva
Coelho, Guilherme
Mandelli, Jovana
Zaffaroni, Facundo
Barrios, Carlos
Graudenz, Marcia Silveira
Cabello, Cesar
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-17-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-17-12
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Prevalence of HER2-low and HER2-zero subgroups and correlation with response to neoadjuvant chemotherapy (NACT) in patients with HER2-negative breast cancer
    Reinert, Tomas
    Sartori, Guilherme Parisotto
    Souza, Alessandra A. B.
    Pellegrini, Rodrigo
    Rosa, Mahira L.
    Rossatto, Nathalia
    Coelho, Guilherme P.
    Litvin, Isnard E.
    Zerwes, Felipe
    Millen, Eduardo
    Cavalcante, Francisco P.
    Frasson, Antonio L.
    Graudenz, Marcia S.
    Barrios, Carlos H.
    CANCER RESEARCH, 2021, 81 (04)
  • [42] Dynamic Changes of HER2 Expression in Breast Cancers after Neoadjuvant Chemotherapy with the Inclusion of HER2-low Category
    Karakas, Cansu
    Tyburski, Haley
    Liu, Elena
    Hicks, David
    Zhang, Huina
    LABORATORY INVESTIGATION, 2023, 103 (03) : S151 - S152
  • [43] Pathologic complete response, long-term outcomes, and recurrence patterns in HER2-low vs HER2-zero breast cancer after neoadjuvant chemotherapy
    Kang, S.
    Lee, S. H.
    Lee, H. J.
    Jeong, H.
    Jeong, J-H.
    Kim, J. E.
    Ahn, J-H.
    Jung, K. H.
    Gong, G.
    Kim, H. H.
    Lee, S.
    Lee, J.
    Kim, S-B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S624 - S624
  • [44] Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis
    Shao, Yingbo
    Yu, Yang
    Luo, Zhifen
    Guan, Huijuan
    Zhu, Fangyuan
    He, Yaning
    Chen, Qi
    Liu, Chaojun
    Nie, Bing
    Liu, Hui
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (13) : 8026 - 8034
  • [45] Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis
    Yingbo Shao
    Yang Yu
    Zhifen Luo
    Huijuan Guan
    Fangyuan Zhu
    Yaning He
    Qi Chen
    Chaojun Liu
    Bing Nie
    Hui Liu
    Annals of Surgical Oncology, 2022, 29 : 8026 - 8034
  • [46] Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy
    Kang, Sora
    Lee, So H.
    Lee, Hee J.
    Jeong, Hyehyun
    Jeong, Jae H.
    Kim, Jeong E.
    Ahn, Jin-Hee
    Jung, Kyung H.
    Gong, Gyungyub
    Kim, Hak H.
    Lee, Saebyeol
    Lee, Jongwon
    Kim, Sung-Bae
    EUROPEAN JOURNAL OF CANCER, 2022, 176 : 30 - 40
  • [47] The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer
    Gülin Alkan Şen
    Esra Aydın
    Murad Guliyev
    Nihan Şentürk Öztaş
    Ezgi Değerli
    Nebi Serkan Demirci
    Zeynep Hande Turna
    Fuat Hulusi Demirelli
    BMC Cancer, 24 (1)
  • [48] Clinical, pathological complete response and prognosis characteristics of HER2-low breast cancer in neoadjuvant chemotherapy setting: A retrospective analysis
    Liu, H.
    Yu, Y.
    Luo, Z.
    Zhu, F.
    He, Y.
    Chen, Q.
    Liu, C.
    Shao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1436 - S1436
  • [49] Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer
    Yoshida, Atsushi
    Hayashi, Naoki
    Suzuki, Koyu
    Takimoto, Masafumi
    Nakamura, Seigo
    Yamauchi, Hideko
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) : 1021 - 1028
  • [50] HER2-low status may predict poor neoadjuvant chemotherapy response in HR-negative breast cancer: a real-world multicenter study
    Xu, Weiwei
    Jiang, Yunshan
    Xu, Lingyun
    Li, Changwen
    Wang, Ji
    Liu, Zhao
    Xue, Dandan
    Gu, Yanlin
    Zhong, Zhaoyun
    He, Shiqing
    Wang, Shui
    Zhou, Wenbin
    Pan, Hong
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (06) : 463 - 471
12345